
Jonas Willmann, MD
@jonas_willmann
Radiation Oncologist | Research scholar @MSKCancerCenter and @Unispital_USZ | interested in 🫁, reirradiation & oligometastatic disease
ID: 2408978660
https://scholar.google.com/citations?user=smUWeEgAAAAJ&hl=en 24-03-2014 13:00:12
271 Tweet
323 Takipçi
663 Takip Edilen

🚨 Just out in Red Journal! We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and CBOS 📊 Real-world SBRT data 🧑⚕️ Lessons on patient selection & risk mitigation redjournal.org/article/S0360-… IJROBP - The Red Journal Gozde Yazici Alper Kahvecioglu MD Ecem Yigit



Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! ASTRO ESTRO the Radiosurgery Society Ben Slotman Simon Lo Dan Ebner Percy Lee MD Shankar Siva Tugce Kutuk, MD, MS practicalradonc.org/article/S1879-…

1/11 Our study on subclonal immune evasion in non-small cell lung cancer has just been published in Cancer Cell cell.com/cancer-cell/fu…

Glad to share our most recent NatureRevClinOncol piec on #microbiota #radiotherapy and #cancer #immunotherapy. Kudos to Jianzhou and the Gustave Roussy team for taking the lead! Fox Chase Cancer Center rdcu.be/ewc0t


New data from the randomized PEMBRO-RT study demonstrate when an ICI-mediated Abscopal effect is most likely to occur in patients with stage IV NSCLC. Ralph Weichselbaum Sean Pitroda, M.D. Amy L. Cummings, MD PhD doi.org/10.1038/s43018…
